Furthermore, related articles highlight the role of tumor-derived EVs in HNSCC: EVs mediate immune suppression and tumor progression by reducing the proliferation of CD8+ T cells and promoting the expansion, suppressive activity, and resistance of apoptosis of regulatory T cells (101). The gene discussed is CD8A; the disease is neoplasm.